Author + information
- Received July 22, 1994
- Revision received February 14, 1995
- Accepted March 20, 1995
- Published online September 1, 1995.
- Hiroshi Ohtani, MDa,
- H. William Strauss, MD*,
- James F. Southern, MD, PhD*,
- Takuya Tamatani, PhD†,
- Masayuki Miyasaka, MD‡,
- Morie Sekiguchi, MD§ and
- Mitsuaki Isobe, MD§,**
- ↵**Address for correspondence: Dr. Mitsuaki Isobe, The First Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto 390, Japan.
Objectives Rats with abdominal heterotopic heart transplants were studied to determine whether cardiac allograft rejection could be assessed by immunoscintigraphy targeting intercellular adhesion molecule-1 (ICAM-1), which was induced on allografted organ cells in association with rejection.
Background It is important to detect early rejection before development of myocyte necrosis. Although a variety of methods for the detection of cardiac rejection have been investigated, histologic inspection of biopsied samples is still used routinely for clinical diagnosis of rejection.
Methods DA rat (RT-1a) hearts were transplanted into PVG rats (RT-1c). Immunohistologic examination of the allografts demonstrated that ICAM-1 induction on vascular endothelial cells was observed as early as 4 days after transplantation in this combination. Thirty-nine allografted rats and seven isografted rats were studied. One day after injection of 100 μCi of 111Inlabeled anti—ICAM-1 monoclonal antibody (1A29), planar images were obtained.
Results Rejecting allografts showed increased radiotracer uptake and could be identified on the images as early as 5 days after transplantation. In contrast, nonrejecting cardiac allografts and isografts did not show specific uptake. Mildly rejecting allografts, with mononuclear cell infiltration but without significant myocyte necrosis, could be scintigraphically identified, and the level of radiotracer uptake reflected the histologic severity of rejection. Accumulation of 111In-labeled monoclonal antibody of isotypematched irrelevant specificity was not detected in the rejecting allografts.
Conclusions These data indicate that ICAM-1 induction can be assessed quantitatively by radioimmunoscintigraphy. Radioimmunoscintigraphy is a sensitive method for early detection and assessment of cardiac allograft rejection.
This investigation was supported in part by a grant from Bristol-Myers Squibb Pharmaceutical Co., Princeton, New Jersey. Fujisawa Pharmaceutical Co., Osaka, Japan supplied the FK506 used in this study.
- Received July 22, 1994.
- Revision received February 14, 1995.
- Accepted March 20, 1995.
- American College of Cardiology